Related Experiment Video
Updated: Feb 15, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Clinical advances in molecular biomarkers for cancer diagnosis and therapy
Seema Sethi1, Shadan Ali, Philip A Philip
1Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Abstract:
Cancer diagnosis is currently undergoing a paradigm shift with the incorporation of molecular biomarkers as part of routine diagnostic panel. The molecular alteration ranges from those involving the DNA, RNA, microRNAs (miRNAs) and proteins. The miRNAs are recently discovered small non-coding endogenous single-stranded RNAs that critically regulates the development, invasion and metastasis of cancers. They are altered in cancers and have the potential to serve as diagnostic markers for cancer. Moreover, deregulating their activity offers novel cancer therapeutic approaches. The availability of high throughput techniques for the identification of altered cellular molecules allowed their use in cancer diagnosis. Their application to a variety of body specimens from blood to tissues has been helpful for appreciating their use in the clinical context. The development of innovative antibodies for immunohistochemical detection of proteins also assists in diagnosis and risk stratification. Overall, the novel cancer diagnostic tools have extended their application as prognostic risk factors and can be used as targets for personalized medicine.
Insights
Molecular biomarkers like microRNAs (miRNAs) are revolutionizing cancer diagnosis and treatment. These small RNAs and other molecules aid in early detection, risk assessment, and personalized medicine strategies.
Area of Science:
- Oncology
- Molecular Biology
- Biomarker Discovery
Background:
- Cancer diagnosis is shifting towards molecular biomarker integration.
- Alterations in DNA, RNA, microRNAs (miRNAs), and proteins are key indicators.
- microRNAs (miRNAs) are small non-coding RNAs crucial in cancer regulation.
Purpose of the Study:
- To highlight the role of molecular biomarkers in modern cancer diagnosis.
- To explore the diagnostic and therapeutic potential of miRNAs.
- To discuss the application of novel diagnostic tools in personalized medicine.
Main Methods:
- High-throughput techniques for identifying altered cellular molecules.
- Analysis of various body specimens (blood, tissues) for biomarkers.
- Development of innovative antibodies for protein detection (immunohistochemistry).
Main Results:
- Molecular alterations, including miRNAs, are significantly altered in cancers.
- Biomarkers are applicable across diverse specimens for clinical use.
- Novel tools aid in diagnosis, risk stratification, and personalized therapy.
Conclusions:
- Molecular biomarkers represent a paradigm shift in cancer diagnosis.
- microRNAs (miRNAs) show promise as diagnostic markers and therapeutic targets.
- New diagnostic tools enhance prognostic assessment and personalized medicine.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...
Gene Therapy
Molecular Models
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.

